200 related articles for article (PubMed ID: 11739639)
1. Correction of delF508-CFTR activity with benzo(c)quinolizinium compounds through facilitation of its processing in cystic fibrosis airway cells.
Dormer RL; Dérand R; McNeilly CM; Mettey Y; Bulteau-Pignoux L; Métayé T; Vierfond JM; Gray MA; Galietta LJ; Morris MR; Pereira MM; Doull IJ; Becq F; McPherson MA
J Cell Sci; 2001 Nov; 114(Pt 22):4073-81. PubMed ID: 11739639
[TBL] [Abstract][Full Text] [Related]
2. Development of substituted Benzo[c]quinolizinium compounds as novel activators of the cystic fibrosis chloride channel.
Becq F; Mettey Y; Gray MA; Galietta LJ; Dormer RL; Merten M; Métayé T; Chappe V; Marvingt-Mounir C; Zegarra-Moran O; Tarran R; Bulteau L; Dérand R; Pereira MM; McPherson MA; Rogier C; Joffre M; Argent BE; Sarrouilhe D; Kammouni W; Figarella C; Verrier B; Gola M; Vierfond JM
J Biol Chem; 1999 Sep; 274(39):27415-25. PubMed ID: 10488073
[TBL] [Abstract][Full Text] [Related]
3. Is CFTR-delF508 really absent from the apical membrane of the airway epithelium?
Borthwick LA; Botha P; Verdon B; Brodlie MJ; Gardner A; Bourn D; Johnson GE; Gray MA; Fisher AJ
PLoS One; 2011; 6(8):e23226. PubMed ID: 21826241
[TBL] [Abstract][Full Text] [Related]
4. MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells.
Dechecchi MC; Nicolis E; Bezzerri V; Vella A; Colombatti M; Assael BM; Mettey Y; Borgatti M; Mancini I; Gambari R; Becq F; Cabrini G
Am J Respir Cell Mol Biol; 2007 May; 36(5):615-24. PubMed ID: 17197571
[TBL] [Abstract][Full Text] [Related]
5. General anesthetic octanol and related compounds activate wild-type and delF508 cystic fibrosis chloride channels.
Marcet B; Becq F; Norez C; Delmas P; Verrier B
Br J Pharmacol; 2004 Mar; 141(6):905-14. PubMed ID: 14967738
[TBL] [Abstract][Full Text] [Related]
6. Activation of G551D CFTR channel with MPB-91: regulation by ATPase activity and phosphorylation.
Dérand R; Bulteau-Pignoux L; Mettey Y; Zegarra-Moran O; Howell LD; Randak C; Galietta LJ; Cohn JA; Norez C; Romio L; Vierfond JM; Joffre M; Becq F
Am J Physiol Cell Physiol; 2001 Nov; 281(5):C1657-66. PubMed ID: 11600430
[TBL] [Abstract][Full Text] [Related]
7. The cystic fibrosis mutation G1349D within the signature motif LSHGH of NBD2 abolishes the activation of CFTR chloride channels by genistein.
Melin P; Thoreau V; Norez C; Bilan F; Kitzis A; Becq F
Biochem Pharmacol; 2004 Jun; 67(12):2187-96. PubMed ID: 15163550
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa Homoserine lactone activates store-operated cAMP and cystic fibrosis transmembrane regulator-dependent Cl- secretion by human airway epithelia.
Schwarzer C; Wong S; Shi J; Matthes E; Illek B; Ianowski JP; Arant RJ; Isacoff E; Vais H; Foskett JK; Maiellaro I; Hofer AM; Machen TE
J Biol Chem; 2010 Nov; 285(45):34850-63. PubMed ID: 20739289
[TBL] [Abstract][Full Text] [Related]
9. F508del-CFTR increases intracellular Ca(2+) signaling that causes enhanced calcium-dependent Cl(-) conductance in cystic fibrosis.
Martins JR; Kongsuphol P; Sammels E; Dahimène S; Aldehni F; Clarke LA; Schreiber R; de Smedt H; Amaral MD; Kunzelmann K
Biochim Biophys Acta; 2011 Nov; 1812(11):1385-92. PubMed ID: 21907281
[TBL] [Abstract][Full Text] [Related]
10. Proteasome-dependent pharmacological rescue of cystic fibrosis transmembrane conductance regulator revealed by mutation of glycine 622.
Norez C; Bilan F; Kitzis A; Mettey Y; Becq F
J Pharmacol Exp Ther; 2008 Apr; 325(1):89-99. PubMed ID: 18230692
[TBL] [Abstract][Full Text] [Related]
11. Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis.
Antigny F; Norez C; Dannhoffer L; Bertrand J; Raveau D; Corbi P; Jayle C; Becq F; Vandebrouck C
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):83-90. PubMed ID: 20203293
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, SAR, crystal structure, and biological evaluation of benzoquinoliziniums as activators of wild-type and mutant cystic fibrosis transmembrane conductance regulator channels.
Marivingt-Mounir C; Norez C; Dérand R; Bulteau-Pignoux L; Nguyen-Huy D; Viossat B; Morgant G; Becq F; Vierfond JM; Mettey Y
J Med Chem; 2004 Feb; 47(4):962-72. PubMed ID: 14761197
[TBL] [Abstract][Full Text] [Related]
13. Correction of G551D-CFTR transport defect in epithelial monolayers by genistein but not by CPX or MPB-07.
Zegarra-Moran O; Romio L; Folli C; Caci E; Becq F; Vierfond JM; Mettey Y; Cabrini G; Fanen P; Galietta LJ
Br J Pharmacol; 2002 Oct; 137(4):504-12. PubMed ID: 12359632
[TBL] [Abstract][Full Text] [Related]
14. Salmeterol restores secretory functions in cystic fibrosis airway submucosal gland serous cells.
Delavoie F; Molinari M; Milliot M; Zahm JM; Coraux C; Michel J; Balossier G
Am J Respir Cell Mol Biol; 2009 Apr; 40(4):388-97. PubMed ID: 18931328
[TBL] [Abstract][Full Text] [Related]
15. The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon.
Mall M; Kreda SM; Mengos A; Jensen TJ; Hirtz S; Seydewitz HH; Yankaskas J; Kunzelmann K; Riordan JR; Boucher RC
Gastroenterology; 2004 Jan; 126(1):32-41. PubMed ID: 14699484
[TBL] [Abstract][Full Text] [Related]
16. Activation of chloride transport in CF airway epithelial cell lines and primary CF nasal epithelial cells by S-nitrosoglutathione.
Servetnyk Z; Krjukova J; Gaston B; Zaman K; Hjelte L; Roomans GM; Dragomir A
Respir Res; 2006 Oct; 7(1):124. PubMed ID: 17022806
[TBL] [Abstract][Full Text] [Related]
17. Modulation of deltaF508 cystic fibrosis transmembrane regulator trafficking and function with 4-phenylbutyrate and flavonoids.
Lim M; McKenzie K; Floyd AD; Kwon E; Zeitlin PL
Am J Respir Cell Mol Biol; 2004 Sep; 31(3):351-7. PubMed ID: 15191910
[TBL] [Abstract][Full Text] [Related]
18. SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis.
Grubb BR; Gabriel SE; Mengos A; Gentzsch M; Randell SH; Van Heeckeren AM; Knowles MR; Drumm ML; Riordan JR; Boucher RC
Am J Respir Cell Mol Biol; 2006 Mar; 34(3):355-63. PubMed ID: 16284361
[TBL] [Abstract][Full Text] [Related]
19. CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium.
Zhang L; Button B; Gabriel SE; Burkett S; Yan Y; Skiadopoulos MH; Dang YL; Vogel LN; McKay T; Mengos A; Boucher RC; Collins PL; Pickles RJ
PLoS Biol; 2009 Jul; 7(7):e1000155. PubMed ID: 19621064
[TBL] [Abstract][Full Text] [Related]
20. Purinergic signaling underlies CFTR control of human airway epithelial cell volume.
Braunstein GM; Zsembery A; Tucker TA; Schwiebert EM
J Cyst Fibros; 2004 Jun; 3(2):99-117. PubMed ID: 15463893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
